TLB NOTE: We do not recommend the COVID shot at all, especially in light of the new VAIDS information associated with the third shot (first booster). But do feel it incumbent on us to make you aware of information concerning the dangers and (supposed) effectiveness of these shots as the information becomes available.
••••
Israeli study finds second COVID booster protects against Omicron but wanes quickly
The study, published in the New England Journal of Medicine, indicates that protection from a second booster mostly wanes after a four-week period
By
A second booster shot of the Pfizer vaccine will provide additional short-term protection against the Omicron variant in older adults, but the shot’s effectiveness will wane after just four weeks and nearly disappear entirely after eight, according to a new study out of Israel.
Protection against severe illness did not wane in the six-week period following the second booster, but the window was too short to determine whether a second booster provided more significant long-term protection against severe illness than just one booster.
The study centered on adults 60 and older. The findings, which were published in the New England Journal of Medicine this week, are consistent with previous evidence that vaccine effectiveness against infection disappears faster than against severe disease.
“For confirmed infection, a fourth dose appeared to provide only short-term protection and a modest absolute benefit,” the study reads.
Israel has already authorized a fourth dose of the Pfizer vaccine — the two-shot vaccine and two boosters — for adults over 60 and other high-risk individuals.
The study results arrive as the U.S. Food and Drug Administration convenes a panel of outside advisers Wednesday to discuss how boosters will be utilized in the states moving forward. Last month, the agency authorized second booster doses of the Pfizer and Moderna vaccines for adults over 50, as well as the immunocompromised.
Though 66% of Americans are vaccinated, just 30% are boosted, suggesting they’ll unlikely decide to get a second booster.
_________
RELATED ARTICLES
Shipments monoclonal antibody treatments to states paused as BA.2 becomes dominant COVID strain
COVID hospitalizations reach two-year low as omicron wave continues to ebb
Toilet-tattling? Trump COVID adviser criticizes ‘smart toilet’ proposal for COVID testing
***********
(TLB) published this article with permission of John Solomon at Just the News. Click Here to read about the staff at Just the News
Some emphasis and pictorial content added by (TLB)
Header featured image (edited) credit: Bottle/Needle/Arne Müseler / CC BY-SA 2.0
••••
••••
Stay tuned to …
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply